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ABSTRACT
Three simple , rapid, sensitive and cost-effective titrimetric and spectrophotometric methods were described for the determination of
metoclopramide (MCP) in its pharmaceutical dosage forms and spiked human urine. The titrimetric methods were based on the diazotization reaction involving the primary amine group of MCP and NaNO2 in acid medium with visual (method A) and potentiometric (method
B) end point detection. The spectrophotometric method (method C) depends upon the diazotization of MCP in acid medium followed by
coupling with diphenylamine to give a red colored chromogen with a wavelength of maximum absorption at 530 nm. The experimental
conditions were optimized. Both the titrimetric methods were applicable over the concentration range of 1.0 - 20.0 mg and the calculations
were based on a 1 : 1 (MCP: NaNO2) reaction stoichiometry. In the spectrophotometric method, Beer’s law was obeyed over the concentration range of 0.3 - 7.5 µg/mL with a molar absorptivity of 4.73 × 104 L/mol cm and Sandell’s sensitivity being 0.007 μg/cm2. The limit of
detection and the limit of quantification were calculated to be 0.22 and 0.67 µg/mL, respectively. The proposed methods were applied to
the determination of MCP in tablets, injection and also in spiked human urine.
Key words: metoclopramide, titrimetry, spectrophotometry, diazotization, diphenylamine

INTRODUCTION
Metoclopramide hydrochloride (MCP), chemically
known
as
4-amino-5-chloro-N-(2-diethylaminoethyl)2-methoxybenzamide hydrochloride, is an antiemetic and
gastroprokinetic agent. Thus it is primarily used to treat
nausea and vomiting, to facilitate gastric emptying in patients
with gastroparesis. It is also used for the prevention of cancer
chemotherapy-induced emesis at much higher doses(1).
The great therapeutic importance of MCP in both
clinical and experimental medicine has resulted in extensive
literature on its determination in dosage forms and biological fluids. Both British Pharmacopoeia(2) and United State
Pharmacopeia(3) describe acid-base titration with potentiometric end point detection. Several methods have been
reported for the determination of MCP in pharmaceuticals,
biological fluids or mixtures with other drugs; by HPLC(411) 1
, H-NMR spectrometry(12), differential scanning calorimetry(13), X-ray powder diffractometry(13), voltammetry(14,15),
potentiometry(16,17), flow-injection chemiluminescence
* Author for correspondence. Tel: +91-821-2419659;
Fax: +91-821-2516133; E-mail: basavaiahk@yahoo.co.in

spectrometry(18-21), fluorimetry(22), UV-spectrophotometry(23) or flow-injection spectrophotometry(24,25). Some of
the reported procedures are not simple for routine analysis
and required expensive or sophisticated instruments. Literature survey revealed that no titrimetric assay of MCP has ever
been reported except the official methods(2,3).
Visible spectrophotometry is perhaps the most widely
used technique reported for the determination of MCP in
pharmaceuticals(26-45) but most of them suffer from one or
other disadvantages like poor sensitivity(26,27,29-31,33,34,41-43),
narrow range of determination(30,34,35,44), need of
heating(26,27,29,31,39) or extraction step(32,33), use of expensive chemicals(42) and non-aqueous systems(30,32,38-40), strict
pH control(32,38) etc.
This paper describes three simple and sensitive titrimetric and spectrophotometric methods for the determination of MCP in its dosage forms. The titrimetric methods is
based on the well-known diazotization reaction with NaNO2
in acid medium and the spectrophotometric method on the
well-characterized coupling with diphenylamine following
the diazotization step.
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MATERIALS AND METHODS

Potentiometric titration was performed with a DI 101
digital potentiometer (Hyderabad, India) equipped with
platinum-calomel electrode system. A Systronics model 106
digital spectrophotometer (Ahmedabad, India) equipped
with 1-cm matched quartz cells was used to measure the
absorbance.

transferred into a series of 100 mL titration flasks, and the
total volume was made up to 10 mL with water. Five millilitres of 5 M HCl were added and the solution was titrated
at room temperature (28 ± 2°C) with 6 mM NaNO2 until
the titration mixture produced distinct blue color on a small
piece of starch iodide paper, which marked the end point.
A blank titration was performed and the volume of NaNO2
consumed by blank was subtracted from the volume required
for sample titration to calculate the amount of NaNO2 which
has been reacted with drug.

II. Reagents and Materials

(II) Potentiometry (method B)

All chemicals and solvents were of analytical-reagent
grade. Distilled water was used throughout the experiment.

Different volumes (1, 2, 3, 4……10 mL) of standard
solution containing 2 mg/mL MCP were taken into a series
of 100 mL beakers and the total volume was adjusted to
10 mL with water. Five millilitres of 5 M HCl were added
and platinum-calomel electrodes were immersed in the
titration liquid. The contents were stirred magnetically and
the titrant (6 mM NaNO2) was added from a microburette.
Near the equivalence point, titrant was added in 0.05 mL
increments. After each addition of titrant, the solution was
stirred magnetically for 30 s and the steady potential was
noted. The addition of titrant was continued until there was
no significant change in potential on further addition of
titrant. The equivalence point was determined by applying
the graphical method. A blank titration was also performed.
In either the titrimetric method, the amount of MCP in
the aliquot was computed from the following formula:

I. Apparatus

(I) Diphenylamine (0.5%)
Five hundred milligrams of the chemical (Merck,
Mumbai, India) was dissolved in glacial acetic acid (Merck,
Mumbai, India) and made up to 100 mL with the same solvent.
(II) Sodium Nitrite (6 mM for methods A and B, and 25 µg/mL
for method C)
The solutions were prepared by dissolving the chemical
(Merck, Mumbai, India) in distilled water.
(III) Sulphuric Acid (5M) and Hydrochloric Acid (5M)
Concentrated sulphuric acid (Merck, Mumbai, India,
sp. gr. 1.84) and concentrated HCl (Merck, Mumbai, India,
sp. gr. 1.18) was appropriately diluted with water to get the
required concentrations.
(IV) Standard Drug Solution
MCP was obtained as gift from IPCA Laboratories
Ltd., Mumbai, India. A stock standard solution of pure drug
containing 2 mg/mL MCP was prepared in water and used in
methods A and B. For method C, the stock solution of 100 μg/
mL MCP was prepared in 10 M acetic acid and the working
standard solution of 15 μg/mL MCP was prepared by dilution
with the same acid.
Two brands of tablets containing MCP, Perinorm-10
(IPCA Laboratories Ltd., Mumbai, India) and Reglan-10
(Cosme farma laboratories Ltd., Karnataka, India); and one
brand of injection containing MCP (5 mg/mL), perinorm
(IPCA Laboratories Ltd., Mumbai, India) used in the investigation were purchased from local commercial sources.
III. Methods
(I) Visual Titrimetry (method A)
Varying aliquots (1, 2, 3, 4…..10 mL) of 2 mg/mL
standard MCP solution were accurately measured and

Amount (mg) =

V x M wt x C
n

where V = mL of NaNO2 consumed
Mw = relative molecular mass of drug
C = concentration of NaNO2, moles/L
n = number of moles of NaNO2 reacting with per mole
of MCP.
(III) Spectrophotometry (method C)
Different aliquots (0.2, 1.0, 2.0, 3.0, 4.0 and 5.0 mL) of
15 μg/mL standard MCP solution were accurately measured
and transferred into a series of 10 mL calibrated flasks using
micro burette and the total volume was adjusted to 5.0 mL
by adding 10 M acetic acid. Two millilitres of 5 M H2SO4
and 1 mL of 25 µg/mL NaNO2 were added; the content was
mixed and kept aside for 5 min. Then, 1 mL of 0.5% diphenylamine was added and the volume was made up to the mark
with water. After 15 min, the absorbance of each solution was
measured at 530 nm against a reagent blank.
Calibration graph was prepared by plotting the
increasing absorbance values versus concentrations of MCP.
The concentration of the unknown was read from the calibration graph or deduced from the regression equation derived
using the Beer’s law data.
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IV. Procedure for Spiked Human Urine
To 50 mL of MCP-free human urine taken in a 125 mL
separating funnel was added with 2.5 mg MCP. Ten millilitres of 1 M NaOH were added, mixed and kept aside for
3 min. Then, 25 mL chloroform was added, shaken well for
about 15 min. The lower organic layer was collected in a
beaker containing anhydrous sodium sulphate. The waterfree organic layer was transferred into a dry beaker and the
solvent evaporated on a hot water bath. The dry residue was
dissolved in 10 M acetic acid and transferred into a 50 mL
calibrated flask, and diluted to the mark with the same acid.
The resulting solution equivalent to 50 µg/mL MCP was
diluted with the same acid to get 15 µg/mL solution and
assayed using the spectrophotometric procedure (method C)
described above.
V. Procedure for Tablets
Twenty tablets containing MCP were weighed and
ground into fine powder. For methods A and B, an accurately weighed amount of the powdered tablet equivalent
to 200 mg of MCP was transferred to a 100 mL calibrated
flask and shaken with 60 mL of water for about 20 min, then
made up to the mark with water, mixed and filtered using
a Whatman No. 42 filter paper. A convenient aliquot (say
5 mL) was taken and assayed according to the procedures
described above. For spectrophotometry (method C), an
amount of powder equivalent to 5 mg of MCP was weighed
into a 50 mL calibrated flask, 20 mL of 10 M acetic acid
was added and the mixture was shaken for 20 min; then
the volume was made up to the mark with the same acid,
mixed well and filtered using Whatman No. 42 filter paper.
The resulting tablet extract containing 100 µg/mL MCP was
diluted appropriately with the same acid to get a working
concentration of 15 µg/mL and subjected to analysis by
following the procedure described above.
VI. Procedure for Injection
The contents of ten ampoules were pooled in a dry
beaker and mixed. The aliquots containing 100 mg of MCP
(method A and B) or 5 mg of MCP (method C) were measured
accurately and transferred to two separate 50 mL calibrated
flasks and diluted with the respective solvents. The resulting

solution (100 µg/mL in MCP) in method C was further
diluted to get 15 µg/mL MCP; and the general procedures
were applied for assay in injection solutions.
VII. Placebo Blank Analysis
A placebo blank of the composition: talc (200 mg),
starch (165 mg), acacia (150 mg), methyl cellulose (200 mg),
sodium citrate (125 mg), magnesium stearate (145 mg)
and sodium alginate (250 mg) was made and its solution
was prepared in 50 mL calibration flask as described under
“Procedure for tablets”, and then subjected to analysis using
the procedures described above.
VIII. Synthetic Mixture Analysis
To the placebo blank of the composition described above,
100 mg of MCP (methods A and B) or 5 mg of MCP (method
C) was added separately and homogenized, transferred to
two separate 50 mL calibrated flasks and the solution was
prepared as described under “Procedure for tablets”, and then
subjected to analysis using the procedures described above.

RESULTS AND DISCUSSION
Diazotization reaction has been widely used for the
determination of aromatic primary amino group containing
compounds of pharmaceutical importance(46-49). NaNO2
generated in situ nitrous acid (HONO) in acid medium and
the nitrous acid reacts with amines to yield diazo compounds.
The synthetic utility of such a reaction is to render the amino
group labile for nucleophilic substitution, as the N2 group
is a better leaving group. Since MCP contains aromatic
primary amine group, the present work employs the same
reaction for its assay and the probable reaction scheme is
given in Scheme 1.
In visual titrimetric method, when the reaction between
the aromatic primary amine group present in MCP with
HONO (generated in situ from NaNO2 under acid medium)
was completed, the excess HONO was detected using
starch iodide paper. Action of starch iodide paper with reaction mixture liberates iodine from iodide in HCl medium.
The liberated iodine reacts with starch to give blue color.
Many internal indicators like metanil yellow, tropaeolin 00,
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Scheme 1. Diazotization of MCP with HONO.
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Figure 1. Typical potentiometric titration curve with a derivative curve for 12 mg MCP Vs 6 mM NaNO2.

CH3

O
Cl
N2+

N
H
OCH3

N

CH3.HCl.H2O

+

NH

H+

Cl
N

DPA

N

Diazotized MCP

CH3

O
N
H
OCH3

N

CH3.HCl.H2O

NH

Pink azo product

Scheme 2. Coupling of diazotized MCP with diphenylamine (DPA) to produce pink azo product.

methylene blue and neutral red were tried, but none of them
was found satisfactory for this titration. Interestingly unlike
in many reported methods, diazotization was achieved at
ambient temperature (28 ± 2°C) and cooling to 0 - 5°C was
not required.
The potentiometric titration used a platinum-calomel
electrode system and the change in electrode potential (EMF)
upon the addition of titrant was noted against the volume of
the NaNO2 added. Liberation of excess nitrous acid at the
end point depolarizes the electrode and the end point was
detected when the EMF increased rapidly (Figure 1). The
stoichiometry of the reaction was assessed and found to be
1 : 1 (MCP : NaNO2).
In the literature, various coupling agents have been
used for the spectrophotometric assay of MCP(46-55), but
diphenylamine was found to excel most of them by offering
better linear dynamic range, sensitivity, non-rigid optimal
experimental conditions and cost-effectiveness. Hence, the
present spectrophotometric method employed diphenylamine
as coupling agent. The work involves coupling of diazotized
MCP with diphenylamine in acidic medium to give a pink
colored azo product. Due to the fact that diazonium cations
are poor electrophiles and relatively bulky species, mainly
para substitution takes place in diazonium coupling(50). In the
case of para substitution, steric hindrance is at its weakest,
while the positive charge’s stabilization is at its largest, in the

σ complex. If the para position is already occupied by another
substituent, ortho substitution occurs(50). In diphenylamine,
since the para position is unoccupied, coupling of diazotized
MCP occurs at para position and the reaction mechanism is
represented in Scheme 2.
Even though diphenylamine and azo product are insoluble in water, they were found to be dissolved easily in acetic
acid medium.
I. Spectral Characteristics
The absorption spectra of the pink colored azo product
with λmax at 530 nm and the reagent blank are shown in
Figure 2. The reagent blank has negligible absorption at this
wavelength.
II. Optimization of Experimental Variables
Various experimental variables were optimized to
achieve the maximum sensitivity.
III. Titrimetry
(I) Sodium Nitrite
In both the titrimetric methods, 6 mM NaNO2 was fixed
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as the optimum concentration, since at this concentration the
volume of NaNO2 required to diazotized completely 10 mL
of 2 mg/mL MCP was below 10 mL.

Sample
Blank
0.6
0.5

The quantitative results were obtained in HCl medium
and the reaction stoichiometry of 1:1 (MCP : NaNO2) was
unaffected in the concentration range of 0.333 - 5.0 M HCl.
Hence, 5 mL of 5 M HCl in a total volume of 10 mL (i. e.
overall concentration of 2.5 M HCl) was fixed as optimum
in both methods.

Absorbance

(II) Hydrochloric Acid.

0.4
0.3
0.2
0.1
0.0

IV. Spectrophotometry

400

450

500

550

600

650

Wavelength, nm

(I) Sodium Nitrite
The amount of NaNO2 required for complete diazotization was found to be 1 mL of 25 µg/mL. There was no change
in the absorbance at higher concentrations.

Figure 2. Absorption spectra of pink color azo product (3 mL of 15 μg/
mL MCP).

0.56

(II) Sulphamic Acid

The effect of diphenylamine concentration on the absorbance of the system was studied by using 0.5% diphenylamine
and the results showed that there was no change in the absorbance from 0.5 - 2.0 mL of 0.5% diphenylamine (Figure 3).
Hence, 1 mL of 0.5% diphenylamine used throughout the
study.
(IV) Sulphuric Acid.
Various acids were tested and H2SO4 was found as the
ideal one in method C, since the color intensity of the azo dye
was found maximum in this medium. H2SO4 concentration
was found to be critical. Only 1.5 - 2.5 mL of 5 M H2SO4
gave maximum and constant absorbance readings; below and
above these concentrations decrease in the absorbance readings was observed (Figure 4). Hence, 2.0 mL of 5 M H2SO4
was fixed in method C.
(V) Reaction Time and Stability of the Reaction Product
Effect of time on both reaction steps (diazotization and
coupling steps) was investigated. Diazotization reaction was
found to be complete at 5 min and the coupling step took 15
min for completion and the azo dye formed remained stable
for more than 24 h.
V. Method Validation

Absorgance

(III) Diphenylamine.

0.48
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Figure 3. Effect of diphenylamine on the absorbance of pink color azo
product (3 mL of 15 μg/mL MCP).

0.5

Absorbance

No change was observed in absorbance in the presence
or absence of sulphamic acid, therefore, the use of sulphamic
acid to destroy excess NaNO2 was avoided.
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Figure 4. Effect of sulphuric acid on the absorbance of pink color azo
product (3 mL of 15 μg/mL MCP).
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(I) Analytical Parameters of Spectrophotometric Method
A linear relation was found to exist between absorbance
and the concentration of MCP in the range of 0.3 - 7.5 μg/mL
(Figure 5).
The calibration graph is described by the equation:
Y=a+bX
(where Y = absorbance, a = intercept, b = slope and X =
concentration in µg/mL) obtained by the method of least
squares. The values of correlation coefficient, intercept and
slope for the calibration data are found to be 0.999, 0.003 and
0.122, respectively. Sensitivity parameters such as apparent
molar absorptivity, Sandell’s sensitivity, the limits of detection (LOD) and quantification (LOQ) calculated as per the
current ICH guidelines(51) are calculated and the respective
values are 4.73 × 104 L/mol cm, 0.007 μg/cm2, 0.22 μg/mL and
0.67 μg/mL. The LOD and LOQ were calculated according to
the same guidelines using the formulae:
LOD = 3.3 σ/s and LOQ = 10 σ/s

Absorbance

where σ is the standard deviation of five reagent blank
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0

0

1

2

3

4

5

6

7

determinations and s is the slope of the calibration curve.
The standard deviation of intercept (Sa) and slope (Sb) were
also calculated and found to be 0.025 for Sa and 0.004 for Sb,
respectively.
(II) Accuracy and Precision
The accuracy and precision of the methods were evaluated by performing seven replicate analyses on pure drug
solution at three different amount/concentration levels (within
the working ranges). The relative error (%), an indicator of
accuracy was within 3.0 and within day precision, also called
the repeatability, expressed as relative standard deviation
(RSD %) was less than 2.0 indicating high accuracy and
repeatability of the methods. The results of the study are given
in Table 1. The reproducibility of the methods also known
as the day-to-day precision was evaluated by performing
replicate analyses on pure drug solution at three levels over a
period of five days, preparing all solutions afresh. The day-today RSD values were less than 2% reflecting the usefulness
of the methods in routine analysis.
(III) Robustness and Ruggedness
Method robustness was tested by making small incremental change in HCl concentration in methods A and B;
and H2SO4 concentration and reaction time were altered in
method C. To check the ruggedness, analysis was performed
by four different analysts; and on three different burettes
(methods A and B) and spectrophotometers (method C) by
the same analyst. The robustness and the ruggedness were
checked at three different drug levels. The intermediate
precision, expressed as percent RSD, which is a measure of
robustness and ruggedness was within the acceptable limits
as shown in Table 2.

8

(IV) Effect of Co-formulated Substances

Concentration of drug, µg/mL

Figure 5. Calibration graph for determination of MCP in spectrophotometric method.

The effect of co-formulated substances was tested by

Table 1. Evaluation of intra-day and inter-day accuracy and precision
Methodsa

MCP taken

Intra-day accuracy and precision
MCP found

%RE

Inter-day accuracy and precision

%RSD

MCP found

%RE

%RSD

Visual titrimetry

6.0

6.14

2.3

0.7

6.16

2.7

1.0

(method A)

12.0

12.21

1.8

0.8

12.27

2.3

1.0

18.0

18.24

1.3

0.7

18.30

1.7

1.0

Potentiometry

6.0

6.11

1.8

0.7

6.17

2.8

1.0

(method B)

12.0

12.19

1.6

0.5

12.25

2.1

1.0

18.0

18.25

1.4

0.6

18.32

1.8

0.7

Spectrophotmetry

1.5

1.48

1.3

0.8

1.54

2.7

0.8

(method C)

4.5

4.60

2.2

0.7

7.5
7.68
2.4
0.8
RE: Relative error and RSD: Relative standard deviation.
a
In titrimetry methods, MCP taken/found are in mg and they are μg/mL in spectrophotometry.

4.63

2.9

0.9

7.71

2.8

0.7
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Table 2. Robustness and ruggedness expressed as intermediate precision (%RSD)

Method robustness
Method

MCP
Takena

Visual titrimetry
(method A)

Method ruggedness

Parameter altered
HClb (5M) mL
RSD, %
(n = 3)

H2SO4c (5 M) mL
RSD, %
(n = 3)

Reaction timed
RSD % (n = 3)

Inter-analysts’ RSD, %
(n = 4)

Inter-instruments’
RSD, %
(n = 3)

6.0

0.7

-

-

0.9

1.8

12.0

0.8

-

-

1.1

0.9

18.0

0.8

-

-

0.9

0.9

Potentiometry

6.0

0.9

-

-

0.7

1.2

(method B)

12.0

0.7

-

-

0.7

0.8

18.0

0.8

-

-

0.7

0.9

Spectrophotometry

1.5

-

0.8

1.0

0.8

1.0

(method C)

4.5

-

0.9

0.8

0.9

1.1

7.5
0.9
0.8
0.8
mg in titrimetry and μg/mL in spectrophotometry.
b
HCl volumes used were 4.8, 5.0 and 5.2 ml in both visual titrimetry and potentiometry.
In spectrophotometric method, cH2SO4 volumes of 1.8, 2.0 and 2.2 ml and dreaction time of 13, 15 and 17 min were employed.
a

placebo blank and synthetic mixture analyses. A convenient
aliquot of the placebo blank solution was subjected to analysis
according to the recommended procedures. In all cases, there
was no interference by the inactive ingredients as indicated
by the near blank absorbance in spectrophotometry and near
blank titre volume in titrimetry.
The analysis of synthetic mixture solution yielded
percent recoveries which ranged between 96.83 and 104.1
with standard deviation of 1.24 - 1.42 in all cases. The results
of this study are presented in Table 3 indicating that the inactive ingredients did not interfere in the assay.
(V) Application of the Proposed Methods to Spiked Human
Urine and Dosage Forms
The proposed spectrophotometric method was successfully applied to the spiked human urine sample. The analysis
of human urine sample spiked with MCP yielded percent
recoveries in the range of 105.7 - 108.2 (n = 5) with standard
deviation of 1.28 - 1.41. In order to evaluate the analytical
applicability of the proposed methods to the quantification of
MCP in commercial tablets and injection, the results obtained
by the proposed methods were compared to those of the reference method(2) by applying Student’s t-test for accuracy and
F-test for precision. In reference method, 0.2500 g of MCP
was dissolved in 5.0 mL of 0.01 M HCl and 50 mL of alcohol;
and the resulting solution was titrated with 0.1 M NaOH to
potentiometric end point detection. The results (Table 4)
show that the Student’s t- and F-values at 95% confidence
level are less than the theoretical values, which confirmed a
good agreement between the results obtained by the proposed
methods and the reference method with respect to accuracy
and precision.

1.0

Table 3. Recovery of the drug from synthetic mixture
MCP in synthetic
mixture takena

MCP recoveredb
(Percent ± SD)

Visual titrimetry

6.0

103.6 ± 1.94

(method A)

12.0

104.1 ± 2.61

Method

18.0

103.4 ± 1.75

Potentiometry

6.0

97.01 ± 1.66

(method B)

12.0

96.83 ± 2.72

18.0

98.78 ± 2.53

Spectrophotometry

1.5

97.39 ± 2.88

(method C)

4.5

97.68 ± 3.71

7.5
98.82 ± 2.59
a
mg in titrimetry and μg/mL in spectrophotometry.
b
Mean value of five determinations.

(VI) Recovery Studies
The accuracy and validity of the proposed methods were
further ascertained by performing recovery studies. Pre-analysed tablet powder was spiked with pure MCP at three levels
(50, 100 and 150% of that found in tablet powder) and the
total was determined by the proposed methods. The percent
recovery of pure MCP added was in the ranged of 97.00
- 104.3% with standard deviation of 1.19 - 1.38 (Table 5)
indicating that the recovery was good and the co-formulated
substance did not interfere in the determination.

Conclusions
Three simple methods for the determination of MCP
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Table 4. Results of analysis of tablets by the proposed methods
Tablet/injection Brand name

Founda (Percent of label claim ± SD)
Label claim,
Visual titrimetry
Potentiometry
mg/tablet
Reference method
(method A)
(method B)

Spectrophotometry
(method C)

Perinorm-10b

10

99.67 ± 1.32

100.98 ± 0.74
t = 2.00
F = 3.18

101.5 ± 0.81
t = 2.77
F = 2.65

98.42 ± 0.58
t = 2.08
F = 5.18

Raglan -10c

10

100.3 ± 0.92

101.0 ± 0.81
t = 1.28
F = 1.29

100.98 ± 0.70
t = 1.33
F = 1.73

98.57 ± 0.71
t = 2.69
F = 1.46

Injection
Perinorm-10b

10

97.33 ± 1.18

98.97 ± 0.86
t = 2.54
F = 1.88

98.35 ± 0.76
t = 1.66
F = 2.41

97.85 ± 0.85
t = 0.81
F = 1.93

a

Mean value of five determinations.
IPCA Laboratories Ltd., Mumbai, India; cCosme farma laboratories Ltd., Karnataka, India.
The value of t (tabulated) at 95% confidence level and for four degrees of freedom is 2.77.
The value of F (tabulated) at 95% confidence level and for four degrees of freedom is 6.39.

b

Table 5. Accuracy assessment by recovery experiments

Pure MCP recoveredb
Percent ± SD

3.0

8.99

97.67 ± 0.72

6.0

11.88

97.00 ± 0.82

6.06

9.0

14.81

97.22 ± 0.79

6.1

3.0

9.23

104. 3 ± 0.65

6.1

6.0

12.32

103.7 ± 0.67

Tablet studied

MCP in tableta

Pure MCP addeda

Visual titrimetry
(method A)

6.06
Perinorm -10

6.06

Potentiometry
(method B)
Spectrophotometry
(method C)
a

Total founda

Methods

Perinorm -10

Perinorm -10

6.1

9.0

15.29

102.1 ± 0.81

2.95

1.5

4.42

98.00 ± 0.62

2.95

3.0

5.93

99.33 ± 0.78

2.95

4.5

7.40

98.89 ± 0.82

mg in titrimetry and μg/mL in spectrophotometry.
b
Mean value of three measurements.

in tablets and in injection were developed and validated
as per the ICH guidelines(51). The methods are based on
well-characterized diazotization/coupling reactions. The
diazocoupling reaction involving diphenylamine has earlier
been used by Abbas Afkhami et. al., for the determination
of nitrite(46); however, the authors have used triton X-100,
a neutral surfactant, for dissolving the reaction product and
ethanol to prepare diphenylamine solution. In the present
work, the use of surfactant and ethanol which are not ecofriendly has been avoided, since diphenylamine and azo dye
were found to be easily dissolved in acetic acid medium.
This is a greener approach and the novelty of the proposed
spectophotometric method. The present titrimetric methods
are the simplest methods ever reported and the visual titrimetric method is the first ever reported for the determination
of MCP. The titrimetric methods are applicable over wide
linear dynamic ranges and were successfully applied to the
tablets and injection. The high sensitivity of the spectrophotometric method enabled its application to the determination

of MCP in spiked human urine besides the dosage forms. The
statistical parameters and recovery study data clearly indicate the reproducibility and accuracy of the methods. Besides
the simplicity and sensitivity of the procedures, the relative
cheapness of apparatus and reagents demonstrate their advantageous characteristics. The methods are also useful due to
high tolerance limit for common excipients found in pharmaceutical formulations. These merits coupled with the use of
simple and inexpensive instrument and high selectivity of the
methods recommend the use of the methods in routine quality
control laboratories.
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